Drawing for ARCRINE

USPTO serial 77192701

ARCRINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ROBERTSON, DEIRDRE G
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ARCRINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pamela A. May

PAMELA A. MAY GLAXOSMITHKLINE709 SWEDELAND ROAD UW2221KING OF PRUSSIA, PA 19406UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccinesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 15, 2008MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Sep 12, 2008ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Sep 12, 2008OP.TOPPOSITION TERMINATED NO. 999999—
Sep 12, 2008OP.SOPPOSITION SUSTAINED NO. 999999—
Jul 25, 2008DOCKASSIGNED TO EXAMINER—
May 16, 2008OP.IOPPOSITION INSTITUTED NO. 999999—
Apr 25, 2008CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Apr 24, 2008APETASSIGNED TO PETITION STAFF—
Apr 14, 2008FAXXFAX RECEIVED—
Dec 17, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 20, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 31, 2007NPUBNOTICE OF PUBLICATION—
Oct 15, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 15, 2007ALIEASSIGNED TO LIE—
Sep 13, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 9, 2007DOCKASSIGNED TO EXAMINER—
Jun 4, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance